Ruxolitinib in Combination with Vorinostat Suppresses Tumor Growth and Alters the Metabolic Phenotype in Haematological Diseases

被引：0
|
作者：
Civallero, Monica
Cosenza, Maria
Marmiroli, Sandra
Pozzi, Samantha
Sacchi, Stefano
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5194
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice
    Wabitsch, Simon
    Tandon, Mayank
    Ruf, Benjamin
    Zhang, Qianfei
    McCallen, Justin D.
    McVey, John C.
    Ma, Chi
    Green, Benjamin L.
    Diggs, Laurence P.
    Heinrich, Bernd
    Greten, Tim F.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 12 (03): : 1166 - 1178
  • [22] Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells
    Lee, Pei-Chih
    Kakadiya, Rajesh
    Su, Tsann-Long
    Lee, Te-Chang
    NEOPLASIA, 2010, 12 (05): : 376 - U2
  • [23] Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model
    Jiangtao Bai
    Qiquan Yu
    Yuyang Wang
    Linshan Xu
    Jianping Wang
    Jianglong Zhai
    Qi Bao
    Wentao Guo
    Chunxiao Wu
    Kun Zhang
    Weizhen Shou
    Guoying Zhu
    Medical Oncology, 40
  • [24] Iodine-125 brachytherapy suppresses tumor growth and alters bone metabolism in a H1299 xenograft mouse model
    Bai, Jiangtao
    Yu, Qiquan
    Wang, Yuyang
    Xu, Linshan
    Wang, Jianping
    Zhai, Jianglong
    Bao, Qi
    Guo, Wentao
    Wu, Chunxiao
    Zhang, Kun
    Shou, Weizhen
    Zhu, Guoying
    MEDICAL ONCOLOGY, 2023, 40 (02)
  • [25] Combination of tumor necrosis factor-α with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice
    Yasui, H
    Adachi, M
    Imai, K
    CANCER, 2003, 97 (06) : 1412 - 1420
  • [26] Combination treatment with SAHA and 5-Azacytidine (Decitabine) induces apoptosis and suppresses tumor growth in preclinical models of chondrosarcoma
    Sheikh, Tahir
    Patwardhan, Parag
    Schwartz, Gary K.
    CANCER RESEARCH, 2017, 77
  • [27] The Prolyl-hydroxylase Inhibitor Alters Tumor-Infiltrating Macrophage Phenotype via the PHD-HIF Axis and Inhibits Tumor Growth in a Mouse Model
    Matsunaga, Shinji
    Hirakawa, Ryo
    Nishide, Shunji
    Kabei, Kazuya
    Tokudome, Kentaro
    Honma, Takujiro
    Uchida, Junji
    Tomita, Shuhei
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 807 - 808
  • [28] hetIL-15 and Fenofibrate combination alters the metabolic fitness of tumor-infiltrating CD8+T cells leading to TNBC tumor eradication in mice
    Stellas, Dimitris
    Karaliota, Sevasti
    Stravokefalou, Vasiliki
    Goldfarbmuren, Katherine C.
    Myers, Breana
    Pavlakis, George N.
    Felber, Barbara K.
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation
    Liu, Yong-Si
    Wang, Jia-Xin
    Jin, Guang-Yi
    Hu, Ming-Hao
    Wang, Xiao-Dong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [30] Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
    de Souza, Cristina Maria
    Araujo e Silva, Ana Candida
    Ferraciolli, Clarissa de Jesus
    Moreira, Giovanna Vieira
    Campos, Liliane Cunha
    dos Reis, Diego Carlos
    Paz Lopes, Miriam Teresa
    Neves Diniz Ferreira, Monica Alves
    Andrade, Silvia Passos
    Cassali, Geovanni Dantas
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (01) : 51 - 57
12345